Literature DB >> 22138086

Interleukin-6 signalling: more than Jaks and STATs.

René Eulenfeld1, Anna Dittrich, Christina Khouri, Pia J Müller, Barbara Mütze, Alexandra Wolf, Fred Schaper.   

Abstract

The hallmark of signalling by many cytokines is the activation of the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) pathway. However, cytokines additionally activate other pathways. In past years we realised that these pathways significantly contribute to the physiological functions of IL-6 and pathophysiological functions in the context of many inflammatory and proliferative diseases. Whereas other articles in this issue of the European Journal of Cell Biology focus on STAT activation and its regulation we here aim to summarise our knowledge and some remaining questions on interleukin-6 (IL-6)-induced STAT-independent pathways as well as the cross-talk with the Jak/STAT pathway. In the early stages of studying cytokine signalling we were used to analysing individual signalling pathways. These days we know about the importance of both, the crosstalk between pathways initiated by combinations of cytokines as well as the crosstalk between individual pathways initiated by a single cytokine. Whereas the inter-cytokine crosstalk can be studied relatively easily, more sophisticated experimental approaches are required to elucidate the intra-cytokine crosstalk.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138086     DOI: 10.1016/j.ejcb.2011.09.010

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  57 in total

Review 1.  Regulating billions of blood platelets: glycans and beyond.

Authors:  Renata Grozovsky; Silvia Giannini; Hervé Falet; Karin M Hoffmeister
Journal:  Blood       Date:  2015-09-01       Impact factor: 22.113

Review 2.  Novel mechanisms of platelet clearance and thrombopoietin regulation.

Authors:  Renata Grozovsky; Silvia Giannini; Hervé Falet; Karin M Hoffmeister
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

3.  Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells.

Authors:  Mahboubeh S Noori; John D O'Brien; Zachary J Champa; Sudhir P Deosarkar; Olivia L Lanier; Chunyan Qi; Monica M Burdick; Frank L Schwartz; Stephen C Bergmeier; Kelly D McCall; Douglas J Goetz
Journal:  Eur J Pharmacol       Date:  2017-03-23       Impact factor: 4.432

4.  Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Sigrun Renate Hofmann; Anne Sophie Kubasch; Ursula Range; Martin Walther Laass; Henner Morbach; Hermann Joseph Girschick; Christian Michael Hedrich
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 5.  Inhibition of IL-6 family cytokines by SOCS3.

Authors:  Jeffrey J Babon; Leila N Varghese; Nicos A Nicola
Journal:  Semin Immunol       Date:  2014-01-10       Impact factor: 11.130

6.  IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Authors:  Poonam Kothari; Roberto Pestana; Rim Mesraoua; Rim Elchaki; K M Faisal Khan; Andrew J Dannenberg; Domenick J Falcone
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

7.  The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Authors:  Renata Grozovsky; Antonija Jurak Begonja; Kaifeng Liu; Gary Visner; John H Hartwig; Hervé Falet; Karin M Hoffmeister
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

8.  Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Authors:  Daniel Kerage; Megan S F Soon; Brianna L Doff; Takumi Kobayashi; Michael D Nissen; Pui Yeng Lam; Graham R Leggatt; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

9.  Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages.

Authors:  Geun Taek Lee; Yeon Suk Jung; Yun-Sok Ha; Jeong Hyun Kim; Wun-Jae Kim; Isaac Y Kim
Journal:  Cancer Sci       Date:  2013-06-28       Impact factor: 6.716

10.  Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Authors:  Doreen M Floss; Simone Mrotzek; Tobias Klöcker; Jutta Schröder; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.